Avenanthramide dicaffeoylquinic acid synergistic complex: SymriseRecent Research Landscape
Poor bioavailability and oxidation of bioactive compounds limit therapeutic efficacy. These innovations engineer specific cereal-derived polysaccharide and antioxidant synergies to enhance skin permeability and chemical stability.
What technical problems is Symrise addressing in Avenanthramide dicaffeoylquinic acid synergistic complex?
Poor bioavailability and degradation
(5)evidences
Low bioavailability of active compounds due to the skin's natural protective layers. Overcoming this resistance ensures therapeutic concentrations reach target dermal tissues.
Inadequate topical ingredient stability
(3)evidences
Compromised epidermal integrity leads to chronic inflammation and moisture loss. Restoring this barrier prevents environmental hypersensitivity and pathological dryness.
Oxidative degradation of lipids
(2)evidences
Lipid-based systems suffer from rapid oxidation and rancidity which limits product shelf life. Preventing this degradation maintains chemical integrity and functional potency.